474
Participants
Start Date
October 31, 2013
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Drug: EVP-6124
Placebo
Phoenix
Tucson
Costa Mesa
Encino
Glendale
Long Beach
Redding
San Diego
Atlantis
Brooksville
Delray Beach
Fort Myers
Lake Worth
Miami
Orlando
St. Petersburg
Weston
Columbus
Douglasville
Chicago
Park Ridge
Baton Rouge
Bangor
Chestnut Hill
Plymouth
Flowood
Creve Coeur
Princeton
Springfield
Brooklyn
Latham
New York
Staten Island
Wilmington
Columbus
Portland
Norristown
Philadelphia
San Antonio
Wichita Falls
Murray
Salt Lake City
Bennington
Williamsburg
Hornsby
Geelong
West Heidelberg
Brussels
Leuven
Saint Truiden
Kelowna
Chatham
Toronto
Gatineau
Nice
Paris
Rouen
Toulouse
Achim
Cologne
München
Nuremberg
Brescia
Milan
Guadalajara
Monterrey
Bialystok
Bydgoszcz
Poznan
Warsaw
Bellville
Johannesburg
Pretoria
Somerset West
Seongnam-si
Busan
Seoul
Elche
Barcelona
Terrassa
Madrid
Burgos
Lead Sponsor
FORUM Pharmaceuticals Inc
INDUSTRY